In vitro DNA and RNA synthesis by human platelets

Area of Science:

• Hematology
• Molecular Biology
• Cell Biology

Background:

• Human platelets, anucleated cell fragments, were traditionally not considered capable of significant nucleic acid synthesis.
• Previous research has not fully elucidated the capacity for DNA and RNA synthesis in platelets and their subcellular components.

Purpose of the Study:

• To investigate the in vitro capacity of human platelets for DNA and RNA synthesis.
• To determine the role of platelet nucleic acid synthesis in protein synthesis.
• To identify the cellular location of these synthetic activities within platelets.

Main Methods:

• In vitro incorporation assays using radiolabeled thymidine (DNA synthesis) and uridine (RNA synthesis).
• Dose- and time-dependent inhibition studies using specific DNA and RNA synthesis inhibitors (hydroxyurea, cytosine arabinoside, daunomycin, actinomycin D, rifampicin, vincristine).
• Analysis of platelet RNA profile using polyacrylamide gel electrophoresis.
• Isolation and study of platelet mitochondria for nucleic acid incorporation.

Main Results:

• Human platelets demonstrated in vitro incorporation of thymidine and uridine, indicating DNA and RNA synthesis.
• Specific inhibitors of DNA and RNA synthesis dose-dependently inhibited these processes.
• Platelet RNA profiles were similar to embryonic erythroblasts, with synthesis of all fractions inhibited by actinomycin D.
• Protein synthesis was inhibited by actinomycin D in a time-dependent manner.
• Isolated platelet mitochondria incorporated radiolabeled thymidine and uridine, with synthesis inhibited by relevant drugs.

Conclusions:

• Human platelets possess the capability for both DNA and RNA synthesis.
• These nucleic acid synthetic activities, likely occurring in platelet mitochondria, play a role in regulating protein synthesis.
• The findings challenge previous assumptions about platelet metabolic capabilities.